Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3038 |
|
| Actual shortage: | 231 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2784 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-07-31 | 2019-08-02 | 90347 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Resolved | 2019-11-20 | 2021-09-01 | 99317 |
| APO-OLOPATADINE | 0.1% | SOLUTION | Actual shortage | 2020-06-04 | 2020-06-04 | 116551 |
| APO-OLOPATADINE | 0.2% | SOLUTION | Actual shortage | 2024-03-27 | 2024-03-27 | 223564 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2017-07-25 | 2017-11-17 | 16895 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16900 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2017-07-25 | 2018-04-23 | 16905 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-01-17 | 2018-04-23 | 36321 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Resolved | 2018-07-04 | 2020-07-11 | 54300 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-07-04 | 2018-11-22 | 54303 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Resolved | 2018-12-12 | 2020-07-11 | 69452 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2018-12-27 | 2020-07-11 | 70532 |
| APO-OLMESARTAN/HCTZ | 25MG 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216717 |
| APO-OLMESARTAN/HCTZ | 12.5MG 20MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216720 |
| APO-OLMESARTAN/HCTZ | 12.5MG 40MG | TABLET | Anticipated shortage | 2024-01-19 | 2024-01-19 | 216723 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2017-07-31 | 2018-01-20 | 17614 |
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2017-08-14 | 2018-01-19 | 19231 |
| APO-OLMESARTAN | 40MG | TABLET | Resolved | 2018-07-11 | 2020-09-01 | 55287 |
| APO-OLMESARTAN | 20MG | TABLET | Avoided shortage | 2018-07-15 | 2018-08-21 | 55801 |
| APO-OLMESARTAN | 20MG | TABLET | Resolved | 2018-12-27 | 2020-08-10 | 70529 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CARBAMAZEPINE | Discontinued | 2020-02-19 | 2020-02-19 | 106679 | ||
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-02-21 | 70802 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-07-13 | 70805 |
| APO-ACETAMINOPHEN EXTRA STRENGTH | 500MG | TABLET | Discontinued | 2019-01-02 | 2019-08-08 | 70807 |
| APO-ACETAMINOPHEN | 325MG | TABLET | Discontinued | 2018-10-11 | 2018-10-11 | 63845 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-09-12 | 40841 |
| ANTI-NAUSEANT | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-10-25 | 40844 |
| ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
| ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
| ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
| ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
| ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2018-10-25 | 2018-10-25 | 65585 |
| ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |